Black Diamond Therapeutics Inc (NASDAQ:BDTX) has a beta value of 2.51 and has seen 1.28 million shares traded in the recent trading session. The company, currently valued at $341.47M, closed the recent trade at $6.07 per share which meant it gained $0.96 on the day or 18.80% during that session. The BDTX stock price is -26.19% off its 52-week high price of $7.66 and 73.31% above the 52-week low of $1.62. The 3-month trading volume is 648.82K shares.
Black Diamond Therapeutics Inc (NASDAQ:BDTX) trade information
Sporting 18.80% in the green today, the stock has traded in the green over the last five days, when the BDTX stock price touched $6.07 or saw a rise of 2.88%. Year-to-date, Black Diamond Therapeutics Inc shares have moved 116.03%, while the 5-day performance has seen it change 25.94%. Over the past 30 days, the shares of Black Diamond Therapeutics Inc (NASDAQ:BDTX) have changed -0.65%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Black Diamond Therapeutics Inc (BDTX) estimates and forecasts
Figures show that Black Diamond Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 102.35% over the past 6 months, with this year growth rate of 21.81%, compared to 14.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -49.79% over the past 5 years.
BDTX Dividends
Black Diamond Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
